A Parry

Summary

Publications

  1. pmc Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate
    A Parry
    Department of Neurology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK
    J Neurol Neurosurg Psychiatry 78:733-4. 2007
  2. ncbi request reprint Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis
    A Parry
    Centre for Functional Magnetic Resonance Imaging of the Brain, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK
    J Neurol 250:171-8. 2003
  3. ncbi request reprint Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
    L Ades
    Service d Hématologie Clinique Hôpital Avicenne, Paris XIII University, Bobigny, France
    Leukemia 19:230-3. 2005

Collaborators

  • Xavier Thomas
  • L Ades
  • J S Miguel
  • J J Sotto
  • H Dombret
  • L Degos
  • O Reman
  • P Fenaux
  • M Fey
  • M Sanz
  • J Y Cahn
  • J H Bourhis
  • B Beve
  • C Chomienne
  • S Chevret
  • A M Stoppa
  • C Garo
  • J Dela Serna
  • A Guerci
  • S de Botton
  • A Stamatoulas

Detail Information

Publications3

  1. pmc Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate
    A Parry
    Department of Neurology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK
    J Neurol Neurosurg Psychiatry 78:733-4. 2007
    ..Treatment with PPS appeared to be safe and well tolerated and was associated with prolonged survival (51 months) when compared to natural history studies. However, PPS treatment did not appear to arrest the progression of the disease...
  2. ncbi request reprint Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis
    A Parry
    Centre for Functional Magnetic Resonance Imaging of the Brain, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK
    J Neurol 250:171-8. 2003
    ..The consequences of reduced inflammation on pathological progression relevant to disability therefore may be present, but substantially delayed. Alternatively, distinct mechanisms may contribute to the two processes...
  3. ncbi request reprint Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
    L Ades
    Service d Hématologie Clinique Hôpital Avicenne, Paris XIII University, Bobigny, France
    Leukemia 19:230-3. 2005
    ....